Lenalidomide has demonstrated single-agent ... specifically neutropenia and thrombocytopenia. Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made ...

The pairing of Revlimid (lenalidomide) and Rituxan (rituximab) – known as the R 2 regimen – has been cleared for patients with previously-treated follicular lymphoma (FL) and marginal zone ...

Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol ...